Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PIMAVANSERIN vs PIPERACILLIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

PIMAVANSERIN vs PIPERACILLIN: Safety Overview

Metric PIMAVANSERIN PIPERACILLIN
Total FAERS Reports 46,338 1,032
Deaths Reported 12,352 175
Death Rate 26.7% 17.0%
Hospitalizations 7,471 576
Average Patient Age 76.5 yrs 56.0 yrs
% Female Patients 38.7% 47.6%
FDA Approval Date Apr 29, 2016 Approved Prior to Jan 1, 1982
Manufacturer Novadoz Pharmaceuticals LLC Provepharm Inc.
Route ORAL INTRAVENOUS
Marketing Status Discontinued Discontinued